Key points are not available for this paper at this time.
Adjuvant therapy with durvalumab, with or without tremelimumab, may have efficacy in patients with limited-stage small-cell lung cancer who do not have disease progression after standard concurrent platinum-based chemoradiotherapy.
Building similarity graph...
Analyzing shared references across papers
Loading...
Cheng et al. (Fri,) studied this question.
www.synapsesocial.com/papers/68e58925b6db643587525346 — DOI: https://doi.org/10.1056/nejmoa2404873
Ying Cheng
David R. Spigel
Byoung Chul Cho
New England Journal of Medicine
Peking University
Zhengzhou University
Sarah Cannon
Building similarity graph...
Analyzing shared references across papers
Loading...